Literature DB >> 11885703

Slow transit constipation in children.

J M Hutson1, J McNamara, S Gibb, Y M Shin.   

Abstract

Patients with chronic constipation that fails to respond to treatment remain a challenge for paediatricians and surgeons. Ongoing work in our institution suggests that a number of children with intractable symptoms have slow transit constipation, which has only been described recently in paediatrics. Common features of slow transit are: delayed passage of the first meconium stool beyond 24 h of age, symptoms of severe constipation within a year, or treatment-resistant 'encopresis' at 2-3 years, soft stools despite infrequent bowel actions, and delay in colonic transit on a transit study. A proportion of children with slow transit constipation have an abnormality of intestinal innervation associated with the dysfunctional colonic motility, recognized as intestinal neuronal dysplasia (IND). Intestinal neuronal dysplasia type B, the most common variant of IND, is defined on rectal biopsy by hyperplasia of the submucosal plexus. On laparoscopic colon muscle biopsy, many specimens show reduced numbers of excitatory substance P-immunoreactive nerve fibres in the circular muscle. Functional markers of the nerves allow new diagnostic criteria to be developed which may also allow a more rational approach to treatment. The aetiology remains obscure and the optimal management poorly defined, although subtotal colectomy, proximal colostomy or appendicostomy (for antegrade enemas) have been tried. Once the anatomy and physiology of the colon in children with slow colonic transit is better understood, we will have defined not only a new form of constipation, but also will be able to consider new therapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11885703     DOI: 10.1046/j.1440-1754.2001.00692.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  8 in total

1.  Gender differences in reduced substance P (SP) in children with slow-transit constipation.

Authors:  Yee Ian Yik; Pamela J Farmer; Sebastian K King; C W Chow; John M Hutson; Bridget R Southwell
Journal:  Pediatr Surg Int       Date:  2011-02-02       Impact factor: 1.827

2.  The effect of food withdrawal in children with rapid-transit constipation.

Authors:  I Kearsey; J M Hutson; B R Southwell
Journal:  Pediatr Surg Int       Date:  2016-05-31       Impact factor: 1.827

3.  Predictors of slow colonic transit in children.

Authors:  Zainab Ridha; Rakesh Quinn; Geoffrey David Hain Croaker
Journal:  Pediatr Surg Int       Date:  2014-12-31       Impact factor: 1.827

Review 4.  Transabdominal electrical stimulation (TES) for the treatment of slow-transit constipation (STC).

Authors:  John M Hutson; Lauren Dughetti; Lefteris Stathopoulos; Bridget R Southwell
Journal:  Pediatr Surg Int       Date:  2015-02-12       Impact factor: 1.827

5.  Standard medical therapies do not alter colonic transit time in children with treatment-resistant slow-transit constipation.

Authors:  Melanie C C Clarke; Janet W Chase; Susie Gibb; Anthony G Catto-Smith; John M Hutson; Bridget R Southwell
Journal:  Pediatr Surg Int       Date:  2009-05-16       Impact factor: 1.827

6.  Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment).

Authors:  Antonio Bove; Massimo Bellini; Edda Battaglia; Renato Bocchini; Dario Gambaccini; Vincenzo Bove; Filippo Pucciani; Donato Francesco Altomare; Giuseppe Dodi; Guido Sciaudone; Ezio Falletto; Vittorio Piloni
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

7.  Factors associated with defecation patterns in 0-24-month-old children.

Authors:  Vildan Taylan Tunc; Aysu Duyan Camurdan; Mustafa N Ilhan; Figen Sahin; Ufuk Beyazova
Journal:  Eur J Pediatr       Date:  2008-02-09       Impact factor: 3.183

8.  Total Glucosides of Paeony Promote Intestinal Motility in Slow Transit Constipation Rats through Amelioration of Interstitial Cells of Cajal.

Authors:  Feiye Zhu; Shan Xu; Yongsheng Zhang; Fangming Chen; Jinjun Ji; Guanqun Xie
Journal:  PLoS One       Date:  2016-08-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.